As a national high-tech enterprise, The Celconta Group has a hard-core consultant team and research and development team, a GMP-like laboratory of more than 10,000 square meters and a complete quality control system. The R&D personnel have rich practical experience in cell drug research and development, clinical research, etc., and the quality control personnel have the background of a large pharmaceutical factory. The preparation of UCMSC(umbilical cord mesenchymal stem cell) passed the quality review inspection of National Institutes for Food and Drug Control.

The Celconta Group takes advantage of its own advantages in cell drug research and development and production, to undertake the process development and production functions of cell drug companies, so that cell drug companies can focus more on cell drug research and development, and develop more and better cell drugs for the benefit of the majority of patients.